Cannabis Strain Names, Genetics and Chemotypes: What Patients Should Understand

Cannabis Strain Names, Genetics and Chemotypes: What Patients Should Understand

Names such as Northern Lights, Jack Herer and Cannatonic have become familiar across the cannabis world. They help patients, clinicians and producers distinguish between products, discuss previous experiences and make sense of an increasingly varied market.

However, a strain name does not tell the whole story.

Two products carrying the same familiar name may differ in cannabinoid strength, terpene profile, aroma, appearance and overall consistency. This does not necessarily mean that one has been incorrectly labelled. It reflects the complicated relationship between a plant’s genetics, its growing environment, the phenotype selected by its producer and the way the finished flower is processed and stored.

For medical cannabis patients, understanding these differences can make product information easier to interpret and help set realistic expectations when changing between cultivars, producers or batches.

What Does a Cannabis Strain Name Actually Mean?

A cannabis strain name is generally used to identify a particular cultivar or family of related genetics. Some names refer to varieties that have been stabilised over many generations, while others describe newer crosses created by combining two or more established genetic lines.

Names are useful, but cannabis naming has never operated under a single universal system.

Different breeders may work with separate versions of similarly named genetics. Producers can also select different phenotypes from within the same genetic line, resulting in plants that share an ancestry but express noticeably different characteristics.

Research examining commercially available cannabis has found that samples sold under the same strain name are not always genetically identical. Other studies have identified considerable chemical variation between products, supporting the idea that a familiar name should be treated as a useful starting point rather than a complete product specification.

This is why patients may sometimes find that one producer’s interpretation of a cultivar smells, tastes or feels different from another version they have previously received.

For readers researching the wider background of individual cultivars, a detailed BudChampion’s cannabis strain database can be useful for comparing reported genetics, characteristics and related varieties. This type of information should be treated as general strain research rather than a guide to the medical suitability of a particular product.

Genetics, Phenotypes and Chemotypes

Several terms are commonly used when discussing cannabis varieties. Although they are related, they do not mean the same thing.

Genetics

A plant’s genetics are the inherited biological information passed down through its parent plants. This genetic foundation influences the characteristics the plant may be capable of expressing, including its structure, flowering behaviour and potential cannabinoid or terpene production.

Genetic lineage can help explain where a cultivar came from. However, lineage alone cannot guarantee that every plant or finished product will be identical.

Phenotype

A phenotype is the observable expression of a plant’s genetics within a particular environment.

Seeds produced from the same parent plants can grow into plants with somewhat different characteristics. One may grow taller, produce a stronger aroma or express a different balance of cannabinoids and terpenes than another.

Commercial producers often select a particular phenotype because it demonstrates desirable qualities such as consistency, structure or chemical composition. A different producer working with the same broader genetic line may select another phenotype.

Chemotype

A chemotype, sometimes called a chemovar in cannabis research, describes a plant or product according to its chemical composition.

This can include:

• THC and CBD concentrations
• Minor cannabinoids
• Dominant terpenes
• The relative proportions of these compounds

For patients, the chemotype of the prescribed product is often more informative than whether a strain has traditionally been described as an indica, sativa or hybrid.

Why Can the Same Strain Vary?

Genetics are only one part of the final result. Several factors can cause products carrying the same strain name to differ.

Phenotype selection

A genetic line may produce several distinct phenotypes. The phenotype chosen by one producer may not be the same as the selection used by another.

This is especially relevant with long-established cultivars that have been preserved, crossed and reinterpreted by multiple breeders over many years. Northern Lights is a good example. It is widely associated with indica-dominant genetics and earthy, sweet or pine-influenced characteristics, but several numbered selections and breeder interpretations have appeared over time.

Readers interested in the strain’s reported background can explore this overview of Northern Lights seeds and genetics. The page provides useful historical and genetic context, but it should not be used to predict the exact composition or medical suitability of a prescribed Northern Lights product.

Growing conditions

Temperature, humidity, lighting, nutrition and plant health can all influence how a plant develops. Even genetically identical plants can show differences when cultivated in separate environments.

Harvest timing

The stage at which a plant is harvested can affect its cannabinoid and terpene composition. Producers may also use different criteria when determining the ideal harvest window.

Drying and curing

The way cannabis flower is dried and cured can make a significant difference to its aroma, moisture level and vapour quality. Poor handling may reduce terpene preservation, while carefully controlled processing can help retain more of the plant’s original profile.

Storage and packaging

Exposure to heat, light, oxygen or unsuitable humidity can alter a product after it has been packaged. The time between production and dispensing may therefore affect the condition in which it reaches the patient.

Batch variation

Plant-based medicines can display a degree of natural variation. Regulated producers use testing and quality-control procedures to keep products within defined specifications, but separate batches may not be completely identical.

Why THC and CBD Percentages Are Not the Entire Picture

THC and CBD are usually the most prominently displayed compounds on medical cannabis labels. They are important because they help patients and prescribers understand the approximate potency and balance of a product.

However, cannabis contains many additional compounds.

Minor cannabinoids may be present in smaller quantities, while terpenes contribute to the product’s aroma and flavour. Common cannabis terpenes include myrcene, limonene, pinene, linalool and beta-caryophyllene.

The significance of particular terpene combinations is still being researched. Patients should therefore be cautious about claims that one individual terpene will reliably produce a particular therapeutic result.

Terpene information can still be useful when comparing products, especially where a patient has identified profiles that they personally tolerate or prefer. It should be considered alongside the cannabinoid content, prescribed dose, product format and advice from the treating clinician.

Are Indica and Sativa Labels Still Useful?

The terms indica and sativa remain widely used, but they can sometimes create overly simple expectations.

Products described as indica are often marketed as physically relaxing or more appropriate for evening use, while sativa-labelled products are frequently associated with alertness and daytime use. Hybrids are presented as occupying the space between them.

In practice, these labels do not provide a reliable chemical breakdown.

Modern cannabis varieties have been crossed extensively, and two products described under the same broad category may have very different cannabinoid and terpene profiles. An individual patient’s response can also vary according to dose, tolerance, other medicines and personal sensitivity.

Rather than relying solely on an indica or sativa label, patients can look at the verified product information and discuss their experience with their prescribing clinician.

What Should Medical Cannabis Patients Prioritise?

Strain history can be interesting and may provide helpful context, but patients should prioritise information relating to the specific medicine they have been prescribed.

This includes:

• The exact product and producer
• Declared THC and CBD content
• The prescribed dose and administration instructions
• Available terpene or laboratory information
• Batch consistency and product condition
• Personal response and unwanted effects
• Advice from the prescribing clinician or dispensing pharmacy

Patients should not alter their dosage or replace a prescribed medicine based solely on general information about a strain name.

It can be helpful to keep notes when beginning a new product or receiving a different batch. Recording the dose, time of administration and relevant observations may make future discussions with a clinician more productive.

Any unexpected or concerning effects should be raised with an appropriate healthcare professional.

Strain Names Are a Starting Point, Not a Guarantee

Cannabis strain names give the industry a shared vocabulary. They help organise products, preserve information about genetic lineages and provide patients with a way to discuss their experiences.

Nevertheless, the name printed on a label cannot fully describe what is inside the container.

Genetic selection, phenotype, cultivation, processing, storage and batch composition all contribute to the finished product. This means that separate versions of Northern Lights, or any other well-known cultivar, may share a historical connection without being chemically or experientially identical.

For medical cannabis patients, strain history is best used as supporting context. Verified product details, professional medical advice and the patient’s own carefully monitored response remain more important than the reputation attached to any individual name.

This article is provided for general educational purposes and does not constitute medical advice. Medical cannabis should only be used as prescribed. Patients should speak to their prescribing clinician or pharmacy before changing their medicine or dosage. Cannabis cultivation without the appropriate license remains illegal in the UK.